Non-clinical assessment of the carcinogenic potential of human insulin analogues

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/SWP/372/01
KeywordsInsulin analogues, carcinogenic potential, mitogenic potential, in vitro assays, in vivo assays
DescriptionThis document provides guidance on the general approach to the assessment of potential mitogenicity and carcinogenicity of new insulin analogues.

Related content

How helpful is this page?

Average rating:

 Based on 25 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
5 ratings

Tell us more